0001638599-21-000602.txt : 20210715 0001638599-21-000602.hdr.sgml : 20210715 20210715181014 ACCESSION NUMBER: 0001638599-21-000602 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210715 FILED AS OF DATE: 20210715 DATE AS OF CHANGE: 20210715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Biggar Stephen R CENTRAL INDEX KEY: 0001340380 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 211093632 MAIL ADDRESS: STREET 1: 860 WASHINGTON STREET 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 3 1 doc3_7292.xml PRIMARY DOCUMENT X0206 3 2021-07-15 1 0001783328 TScan Therapeutics, Inc. TCRX 0001340380 Biggar Stephen R 860 WASHINGTON STREET, 3RD FLOOR NEW YORK NY 10014 1 0 0 0 No securities are beneficially owned /s/ Stephen R. Biggar 2021-07-15